Understanding how Ilheus virus infects mammalian and mosquito cells
Official title: Insights into infection of Ilheus virus in mammalian and mosquito cells
Funded at State University of New York at Albany · NIH-11047311 · Data updated 2026-11-12
This study is looking at how the Ilheus virus, which spreads through mosquitoes and can make people and animals sick, works in different types of cells, so we can find better ways to prevent and treat infections.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Albany NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project start | November 15, 2024 |
| Project end | October 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $74,700 |
| NIH project number | 1R03AI188527-01 |
| Project ID | NIH-11047311 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living in areas where Ilheus virus is prevalent or those who have been exposed to mosquito bites in such regions.
✕Less likely to help
Patients who are not at risk of exposure to mosquito-borne viruses or who live in regions where the Ilheus virus is not present may not benefit from this research.
What this research studies
This research investigates the Ilheus virus, a mosquito-borne virus that can cause serious diseases in humans and animals. The study focuses on how the virus interacts with mammalian and mosquito cells, aiming to uncover the mechanisms of infection and transmission. By examining the virus's behavior in different cell types, researchers hope to identify potential antiviral strategies. This work is crucial as current treatments and vaccines for related viruses are limited.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective antiviral treatments for infections caused by Ilheus virus and similar flaviviruses.
How similar studies have gone: While research on Ilheus virus is limited, studies on related flaviviruses have shown promise in understanding their infection mechanisms and developing antiviral therapies.
Where this research is happening
-
State University of New York at Albany
Albany, United States Active
Researchers
- Principal investigator: Pager, Cara Theresia — State University of New York at Albany
- Study coordinator: Pager, Cara Theresia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.